Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embolic problems in angiography.

P Dawson1

  • 1Department of Radiology, Hammersmith Hospital, London, England.

Seminars in Hematology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Non-ionic contrast agents do not increase thrombotic risk; they possess reduced anticoagulant and antiplatelet effects compared to ionic agents. Other materials used in angiography significantly influence thromboembolic events more than contrast agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining spatial variation for immunisation coverage in pregnant women: A nationwide and geospatial retrospective cohort study in Aotearoa New Zealand.

Social science & medicine (1982)·2023
Same author

Publisher Correction: Impact of alloy fluctuations and Coulomb effects on the electronic and optical properties of c-plane GaN/AlGaN quantum wells.

Scientific reports·2020
Same author

Impact of alloy fluctuations and Coulomb effects on the electronic and optical properties of c-plane GaN/AlGaN quantum wells.

Scientific reports·2019
Same author

The Ostom-i™ Alert Sensor: a new device to measure stoma output.

Techniques in coloproctology·2018
Same author

Resonant photoluminescence studies of carrier localisation in c-plane InGaN/GaN quantum well structures.

Journal of physics. Condensed matter : an Institute of Physics journal·2018
Same author

Origin of enhancement in Raman scattering from Ag-dressed carbon-nanotube antennas: experiment and modelling.

Physical chemistry chemical physics : PCCP·2018
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Area of Science:

  • Radiology and Medical Imaging
  • Cardiovascular Research
  • Biomaterials Science

Background:

  • Contrast agents, including non-ionic types, exhibit anticoagulant and antiplatelet properties.
  • Concerns regarding prothrombotic potential of non-ionic contrast agents lack in vitro and in vivo evidence.
  • Non-ionic agents demonstrate reduced anticoagulant effects compared to ionic agents, attributed to their inertness and biocompatibility.

Purpose of the Study:

  • To evaluate the thrombogenic potential of non-ionic contrast agents.
  • To compare the anticoagulant and antiplatelet effects of non-ionic versus ionic contrast agents.
  • To assess the contribution of contrast agents versus other materials to thromboembolic phenomena in angiography.

Main Methods:

  • Review of existing in vitro and in vivo data on contrast agent thrombogenicity.

Related Experiment Videos

  • Clinical experience and observational data from European centers post-introduction of non-ionic agents.
  • Experimental assessment of the role of various materials (catheters, guidewires) in thromboembolism.

    • Main Results:

    • No evidence supports a prothrombotic or thrombogenic potential for non-ionic contrast agents.
    • Non-ionic agents possess a lesser anticoagulant effect than ionic agents, which is predictable and linked to their biocompatibility.
    • Clinical experience shows no increase in thromboembolic events with non-ionic agent use.
    • Experimental data indicates that catheter and guidewire materials play a more significant role in thromboembolism than contrast agents.
    • The role of heparinization remains debated, with no clear consensus on its benefit or optimal monitoring.

    Conclusions:

    • Non-ionic contrast agents are not prothrombotic and offer a favorable safety profile regarding thromboembolic events.
    • Achieving stronger anticoagulant effects in non-ionic agents may necessitate compromising their biocompatibility and increasing toxicity.
    • Angiographers should consider the thrombogenic impact of materials like catheters and guidewires, alongside contrast agent properties.
    • Further research is needed on heparinization protocols in angiography to optimize patient outcomes.